title: Relationship between initial prostate specific antigen level and subsequent prostate cancer detection in a longitudinal screening study.
abstract: OBJECTIVE
  Previous studies of archived blood samples from nonscreened populations have shown an association between the prostate specific antigen (PSA) and the subsequent detection of prostate cancer. In the current study we evaluated the relationship between the initial screening PSA and the subsequent risk of prostate cancer detected in a prospective, longitudinal screening study. We also examined the relationship between initial PSA and the clinicopathological features of the cancers detected.
  
  
  METHODS
  Between May 1991 and November 2001 we enrolled 26,111 volunteers in our PSA and digital rectal examination based prostate cancer screening study. The men were followed biannually or annually depending on the results of previous screening tests. The chi-square and Kruskal-Wallis tests were used to compare the clinical stage, pathological stage and Gleason score of subsequently detected prostate cancers as well as the time to cancer detection in different initial screening PSA strata.
  
  
  RESULTS
  The initial screening PSA stratum was strongly associated with the subsequent detection of prostate cancer as well as the clinicopathological stage and grade of the cancers detected.
  
  
  CONCLUSIONS
  Even in the lower PSA ranges initial screening serum PSA can help identify men at increased risk for subsequent prostate cancer detected in a longitudinal screening study.
authors.affiliation: Departments of Neurology, Washington University, School of Medicine, St. Louis, Missouri, USA.
authors.forename: Jo Ann V
authors.initials: JA
authors.lastname: Antenor
authors.forename: Misop
authors.initials: M
authors.lastname: Han
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Roehl
authors.forename: Robert B
authors.initials: RB
authors.lastname: Nadler
authors.forename: William J
authors.initials: WJ
authors.lastname: Catalona
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000453:epidemiology / Q000473:pathology; D018570:Risk Assessment
chemical_list: D017430:Prostate-Specific Antigen